COVAXIN, India’s COVID Vaccine

COVAXIN, India’s COVID Vaccine –

Bharat Biotech, an Indian biotechnology company, is with the National
Institute of Virology to develop an inactivated vaccine candidate for COVID-
called Covaxin.

A Phase 1/2 trial of about 1,100 healthy participants
is underway after approval by the Drug Controller General of India.

More with Covaxin, Bharat Biotech is working on two other vaccine
candidates: one with the University of Wisconsin–Madison and FluGen, and
the other with Thomas Jefferson University.

Check Out –

Cure COVID !

 2,987 total views,  6 views today

Leave a Reply

Your email address will not be published. Required fields are marked *